FDA extends deadline for stem cell clinics to comply with agency rules

FDA extends deadline for stem cell clinics to comply with agency rules

STAT Plus: FDA extends deadline for stem cell clinics to comply with drug development rules 

By ANDREW JOSEPH

SÍLVIA A FERREIRA, CRISTINA LOPO AND EILEEN GENTLEMAN, KCL/WELLCOME

The FDA gave clinics that offer stem cell-based treatments six more months to start complying with FDA drug development rules, citing the coronavirus pandemic.

READ MORE